The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $28.96

Today's change-0.31 -1.06%
Updated April 29 4:04 PM EDT. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $28.96

Today's change-0.31 -1.06%
Updated April 29 4:04 PM EDT. Delayed by at least 15 minutes.

AstraZeneca PLC crosses below 50-day moving average

AstraZeneca PLC closed lower Friday, dropping (U.S.)$0.31 or 1.06% to (U.S.)$28.96 and crossing below its 50-day moving average. Over the last five days, shares have lost 3.79% and sit 4.62% above their 52-week low. This security has underperformed the S&P 500 by 13.82% during the last year.

Key company metrics

  • Open(U.S.) $29.73
  • Previous close(U.S.) $29.27
  • High(U.S.) $29.76
  • Low(U.S.) $28.88
  • Bid / Ask-- / --
  • YTD % change-14.70%
  • Volume4,752,661
  • Average volume (10-day)3,957,252
  • Average volume (1-month)3,879,389
  • Average volume (3-month)4,444,327
  • 52-week range(U.S.) $27.68 to (U.S.) $35.34
  • Beta0.69
  • Trailing P/E25.94×
  • P/E 1 year forward14.45×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield4.83%
  • Trailing EPS(U.S.) $1.12
Updated April 29 4:04 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue6,3995,9456,3076,057
Total other revenue--------
Total revenue6,3995,9456,3076,057
Gross profit5,1644,9275,2984,831
Total cost of revenue1,2351,0181,0091,226
Total operating expense5,3114,7755,3845,124
Selling / general / administrative2,5602,2992,3002,445
Research & development1,5671,4001,3561,280
Depreciation / amortization360234376265
Interest expense (income), net operating--------
Unusual expense (income)102322343321
Other operating expenses, total-513-4980-413
Operating income1,0881,170923933
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax802931658678
Income after tax808770696552
Income tax, total-6161-38126
Net income808770697550
Total adjustments to net income--------
Net income before extra. items808770697550
Minority interest001-2
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items808770697550
Inc. avail. to common incl. extra. items808770697550
Diluted net income808770697550
Dilution adjustment00--0
Diluted weighted average shares1,2651,2651,2651,265
Diluted EPS excluding extraordinary itemsvalue per share0.640.610.550.43
Dividends per sharevalue per share1.900.000.900.00
Diluted normalized EPSvalue per share0.860.860.830.70